All In MedTech

FDA Clearance Tracker · P980003-S061

CHILLI II COOLED ABLATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 8, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 8, 2016

Approved

Time to decision

224 days

Received Jun 29, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P980003-S061
Device name
CHILLI II COOLED ABLATION SYSTEM
Applicant location
San Jose, CA
Received
Jun 29, 2015
Decided
Feb 8, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P980003

Device type

Device class
Class III

Every decision under product code LPB

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located in Heredia, Costa Rica.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.